Literature DB >> 11839579

Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Donatella Aldinucci1, Dalisa Poletto, Annunziata Gloghini, Paola Nanni, Massimo Degan, Tiziana Perin, Paola Ceolin, Francesca Maria Rossi, Valter Gattei, Antonino Carbone, Antonio Pinto.   

Abstract

The human interleukin-3 receptor (IL-3R) is a heterodimeric complex consisting of an IL-3-specific alpha chain (IL-3Ralpha) and a common beta chain (beta(c)), this latter shared with the receptors for granulocyte-macrophage colony-stimulating factor and IL-5. Despite extensive research on cytokine circuitries regulating proliferation and survival of tumor cells in Hodgkin's disease (HD) the functional expression of IL-3Rs in this pathobiological entity has not yet been investigated. In the present study, we demonstrate that the great majority (>90%) of malignant Hodgkin and Reed-Sternberg cells of classic HD (19 of 19 analyzed cases) express IL-3Ralpha by immunostaining of frozen sections and cell suspensions from involved lymph nodes. Accordingly, HD cell lines (L428, KMH2, HDLM2, L1236) expressed the alpha and beta chains of IL-3R both at the mRNA and protein level, with a molecular size of IL-3Ralpha identical (70 kd) to that expressed by human myeloid cells. Exogenous IL-3 promoted the growth of cultured Hodgkin and Reed-Sternberg cells, such effect being potentiated by IL-9 co-stimulation, and was able to partially rescue tumor cells from apoptosis induced by serum deprivation. This data suggests an involvement of IL-3/IL-3R interactions in the cellular growth of HD through paracrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839579      PMCID: PMC1850655          DOI: 10.1016/S0002-9440(10)64878-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  66 in total

Review 1.  Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs.

Authors:  W L Blalock; C Weinstein-Oppenheimer; F Chang; P E Hoyle; X Y Wang; P A Algate; R A Franklin; S M Oberhaus; L S Steelman; J A McCubrey
Journal:  Leukemia       Date:  1999-08       Impact factor: 11.528

2.  Reed-Sternberg cell genome expression supports a B-cell lineage.

Authors:  J Cossman; C M Annunziata; S Barash; L Staudt; P Dillon; W W He; P Ricciardi-Castagnoli; C A Rosen; K C Carter
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

Review 3.  Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies.

Authors:  H Stein; M Hummel
Journal:  Semin Hematol       Date:  1999-07       Impact factor: 3.851

4.  Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.

Authors:  L Trentin; R Zambello; C Agostini; C Enthammer; A Cerutti; F Adami; S Zamboni; G Semenzato
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

Review 5.  The antigen-presenting cell function of Reed-Sternberg cells.

Authors:  J Delabie; W C Chan; D D Weisenburger; C De Wolf-Peeters
Journal:  Leuk Lymphoma       Date:  1995-06

6.  Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist.

Authors:  Q Sun; J M Woodcock; A Rapoport; F C Stomski; E I Korpelainen; C J Bagley; G J Goodall; W B Smith; J R Gamble; M A Vadas; A F Lopez
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

7.  Characterization of human leucocytes bearing the IL-3 receptor.

Authors:  P J Macardle; Z Chen; C Y Shih; C M Huang; H Weedon; Q Sun; A F Lopez; H Zola
Journal:  Cell Immunol       Date:  1996-02-25       Impact factor: 4.868

8.  IL-3 augments TCR-mediated responses of type 2 CD4 T cells.

Authors:  Y Dan; Y Katakura; A Ametani; S Kaminogawa; Y Asano
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

9.  Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

Authors:  J Wolf; U Kapp; H Bohlen; M Kornacker; C Schoch; B Stahl; S Mücke; C von Kalle; C Fonatsch; H E Schaefer; M L Hansmann; V Diehl
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

10.  Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.

Authors:  A Carbone; A Gloghini; V Gattei; D Aldinucci; M Degan; P De Paoli; V Zagonel; A Pinto
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

View more
  12 in total

1.  Interleukin-3 receptors in Hodgkin's disease.

Authors:  Herbert Bosshart
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

2.  Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.

Authors:  Marco Ruella; Michael Klichinsky; Saad S Kenderian; Olga Shestova; Amy Ziober; Daniel O Kraft; Michael Feldman; Mariusz A Wasik; Carl H June; Saar Gill
Journal:  Cancer Discov       Date:  2017-06-02       Impact factor: 39.397

3.  Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model.

Authors:  Mariko Kawakami; Koji Kawakami; Mitomu Kioi; Pamela Leland; Raj K Puri
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

Review 4.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

Review 5.  Mechanisms underlying the association between obesity and Hodgkin lymphoma.

Authors:  Andreia Matos; Joana Marinho-Dias; Sofia Ramalheira; Maria José Oliveira; Manuel Bicho; Ricardo Ribeiro
Journal:  Tumour Biol       Date:  2016-07-27

Review 6.  The role of T cells in the microenvironment of Hodgkin lymphoma.

Authors:  Frederik Wein; Ralf Küppers
Journal:  J Leukoc Biol       Date:  2015-08-28       Impact factor: 4.962

Review 7.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

Review 8.  Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma.

Authors:  Katerina Vrzalikova; Taofik Sunmonu; Gary Reynolds; Paul Murray
Journal:  Pathogens       Date:  2018-06-27

Review 9.  The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good.

Authors:  Victoria Menéndez; José L Solórzano; Sara Fernández; Carlos Montalbán; Juan F García
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639

10.  Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1.

Authors:  Daniel Ernst; Brent A Williams; Xing-Hua Wang; Nara Yoon; Kyung-Phil Kim; Jodi Chiu; Zhi Juan Luo; Karin G Hermans; Joerg Krueger; Armand Keating
Journal:  Blood Cancer J       Date:  2019-01-15       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.